Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy.

A legfontosabb adatok

Ki végzi
Amsterdam UMC, location VUmc
Hol
Hollandia10 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
66 fő, tervezett
Kezdés
2024. júl. 19.
Várható befejezés
2027. aug. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • MegaPower training
  • Usual Care
A regiszteradat frissítve
2025. december 29.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for children aged 4 to 12 with cerebral palsy, or a related disorder that does not get worse, who can walk. It compares 12 weeks of MegaPower training with usual care.

Életkor
4 to 12 years
Nem
All sexes
A betegség stádiuma
Cerebral palsy or a related non-progressive disorder, GMFCS level I - III (children who can walk). Parents and/or the child have a treatment question about the child's participation in daily activities.
Korábbi kezelés
No botulinum toxin in the 12 weeks before, no serial casting in the 3 weeks before. No selective dorsal rhizotomy or lower-limb orthopedic surgery in the 12 months before. No MegaPower training in the last 4 months.

A részvétel fő kizáró okai

  • A neurological disorder that gets worse over time
  • Botulinum toxin and/or serial casting of the legs planned during the study
  • Recent botulinum toxin, serial casting, selective dorsal rhizotomy or leg surgery
  • MegaPower training in the last 4 months
  • Walking is not (yet) the child's preferred way of moving around

A regiszter feltételei, szó szerint

Mind a 11 feltétel megnézéseKevesebb

Ki vehet részt

  • Children with cerebral palsy or a related non-progressive disorder between the ages of 4 to 12
  • Gross Motor Function Classification System (GMFCS) level I - III
  • Parents and/or children have a treatment question related to participation of the child

Ki nem vehet részt

  • Treatment with botulinum toxin and/or serial casting in lower extremities planned during the study period
  • Treatment with botulinum toxin in the twelve weeks prior to participation in the study
  • Treatment with serial casting in the three weeks prior to participation in the study
  • Children that underwent a selective dorsal rhizotomy twelve months prior to participation in the study
  • Children that underwent orthopedic surgery on their lower extremities in the 12 months before participation in the study
  • Children that have received MegaPower training in the last 4 months before participation in the study
  • Participants that suffer from a progressive neurological disorder
  • Children for whom walking is not their preferred method of locomotion (yet)

Nézd meg, megfelelhetsz-e

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 4 és 12 év között vagy?

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Rationale: Children with cerebral palsy (CP) experience limitations in walking ability due to functional motor impairments caused by neurodevelopmental damage during fetal or early child development. Due to these motor impairments, children with CP struggle to keep up with typically developing peers when participating in physical and/or social activities. Consequently, the development of these children may be hampered. Recently, functional power training (FPT) emerged as a potentially successful supplementary treatment method to improve participation in children with CP. It is understood that FPT is more effective than progressive resistance training in improving walking ability and endurance, and thereby better supports participation in ambulatory children with CP. Nevertheless, high-level scientific evidence underpinning the efficacy of FPT on these parameters in ambulant children with CP is still lacking. The investigators hypothesize that FPT effectively helps accomplish patient-tailored participation and activity goals in ambulant children with CP.

A teljes eredeti leírásKevesebb

Objective: This study aims to investigate whether twelve weeks of FPT (MegaPower training) effectively accomplish patient-tailored participation and activity goals in ambulant children with CP, when compared to their usual care. Additionally, the goal is to investigate i) whether MegaPower training improves walking ability, aerobic endurance, and anaerobic capacity; ii) what factors best identify which ambulant children with CP benefit most from twelve weeks of MegaPower training; iii) to what extend the MegaPower training was implemented as intended in the participating study centers?, and iv) whether the effects of the MegaPower training are maintained after 12 and 24 weeks of follow-up.

Study design: A single-blind randomized controlled parallel trial with a 24 week follow-up. During the follow-up, the control group will also receive MegaPower training.

Study population: Ambulant children with cerebral palsy or a related non-progressive disorder between the ages of 4 - 12.

Intervention: One group will receive twelve weeks of FPT (MegaPower training), whilst the other group will receive twelve weeks of usual care (control group).

Main study parameters/endpoints: Accomplishment of patient-tailored participation and activity goals, measured through Goal Attainment Scaling.

A vizsgálat 2 csoportja

  • Intervention (MegaPower training)A vizsgált kezelés

    MegaPower training is a twelve-week long functional power training program in which children will perform functional power training three times a week together with a personal trainer. During the intervention, training volume will be influenced by training weight, velocity of movement, and amount of repetitions. The training program has the following characteristics: 1. (Weighted) functional exercises like walking, running, and walking stairs. 2. High velocity movements. 3. Progressive overload. Prior to and during the training, a physiotherapist makes a personalized participation plan for the child. This plan is used to tackle participation barriers related to their goal (not directly related to mobility; e.g. beliefs or behaviours) encountered by the child (e.g. involving parents, a sports consultant, a psychologist). Both at twelve and twenty-four weeks during the follow-up, parent and child will visit again to measure whether the effects on participation are long-lasting.

    Kezelés: MegaPower training

  • Control (Usual Care)Már használt kezelés, összehasonlításként

    The control group will receive their usual care for twelve weeks (non-intervention group). This usual care consists of physiotherapy appointments, for example.

    Kezelés: Usual Care

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy - A Randomized Controlled Trial
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Illeszkedési kérdések
Forrás: NCT06640894: ki vehet részt
A regiszteradat frissítve
2025. december 29.